Journals / İstanbul Journal of Pharmacy / 2017 / Cilt: 47 - Sayı: 1

Drug and Herb induced liver injury: a short review

Pages
24–29
Publication Date
2017-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we researched that mechanisms of liver injury with drugs and herbal preparations, and potential risks have been reported.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chemical induced liver injury is a pathological condition caused by diver’s medications and other xenobiotics, leading to deficiencies in liver functions with the elimination of other diagnosis.
📊
Key Findings & Data:Chemical induced liver injury has an estimated annual incidence 10-15 per 10,000-100,000 patients received several prescription medications.
💡
Conclusion & Impact:In this review, we researched that mechanisms of liver injury with drugs and herbal preparations, and potential risks have been reported.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Liver injury · hepatotoxicity · drug withdrawal

Abstract

Chemical induced liver injury is a pathological condition caused by diver’s medications and other xenobiotics, leading to deficiencies in liver functions with the elimination of other diagnosis. Liver injury is prevalent in the world and can result in serious clinical outcome and has possibly fatal outcome. Chemical induced liver injury has an estimated annual incidence 10-15 per 10,000-100,000 patients received several prescription medications. The kind of liver injury are almost 10% cases with acute hepatitis, and is the most common cause of acute liver failure in the United States. Also, liver injury appeared after approval for marketing has restricted the use of many drugs (e.g., isoniazid, labetalol, and felbamate). Therefore, especially drug-induced liver injury is currently the major reason for discontinuation of a new compound in development or for withdrawal of a successfully launched drug from the market. In this review, we researched that mechanisms of liver injury with drugs and herbal preparations, and potential risks have been reported.

🔖

Cite This Article

Çeliksöz, M., Hün, B., Özhan, G. (2017). Drug and Herb induced liver injury: a short review. İstanbul Journal of Pharmacy, Cilt: 47 - Sayı: 1, 24–29. https://ajindex.com/articles/92735

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abdualmjid RJ, Sergi C (2013). Hepatotoxic botanicals-An evidence- based systematic review. J Pharm Pharm Sci 16(3): 376–404. [CrossRef ] • Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y (2014). Human drug-induced liver injury severity is highly associated to dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology 60:1015–1022. [CrossRef ] • Björnsson E (2016). Hepatotoxicity by drugs: the most common ımplicated agents. Int J Mol Sci 17(2): 224. [CrossRef ] • Björnsson ES, Hoofnagle JH (2016). Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports. Hepatology 63(2): 590–603. [CrossRef ] • Boelsterli UA, Lim PLK (2007). Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharm 220(1): 92–107. [CrossRef ] • Bunchorntavakul C, Reddy KR (2013). Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 37(1): 3–17. [CrossRef ] • Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J (2008). Causes, clinical features, and outcomes from a prospective study of drug-ınduced liver ınjury in the United States. Gastroenterology 135(6): 1924–1934. [CrossRef ] • Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI (2015). Druginduced liver injury: interactions between drug properties and host factors. J Hepatol 63(2): 503–514. [CrossRef ] • Clinical P (2009). Guidance for industry drug-induced liver injury: premarketing clinical evaluation. Drug Safety July, 28. Dağ MS, Aydınlı M, Öztürk ZA, Türkbeyler IH, Koruk I, Savaş MC, Koruk M, Kadayıfçı A (2014). Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol 25: 41–45. [CrossRef ] • Daly AK (2012) Genetic polymorphisms affecting drug metabolism: Recent advances and clinical aspects. Adv. Pharmacol. 63: 137–167. [CrossRef ] • Dara L, Hewett J, Lim JK (2008). Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 14(45): 6999–7004. [CrossRef ] • Federal Register. (2012). Patient protection and affordable care act; standards related to essential health benefits, actuarial value, and accreditation. Department of Health and Human Services, Part V, 77 (227): 70644–70676. • Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J (2009). Drug-induced liver injury network (DILIN) prospective study: rationale, des